{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:47:48Z","timestamp":1789508868083,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Pudong New Area People\u2019s Hospital Qihang Plan Talent Cultivation Projec","award":["PRYQH202405"],"award-info":[{"award-number":["PRYQH202405"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24969-7","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:51:24Z","timestamp":1763635884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Crotonoside exerts anti-colorectal cancer effects by suppressing KIF20A to regulate the cell cycle"],"prefix":"10.1038","volume":"15","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"3","key":"24969_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"24969_CR2","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi, Y. & Xu, P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 14 (10), 101174 (2021).","journal-title":"Transl Oncol."},{"issue":"2","key":"24969_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan, E. et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72 (2), 338\u2013344 (2023).","journal-title":"Gut"},{"issue":"4","key":"24969_CR4","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/cam4.1416","volume":"7","author":"D Li","year":"2018","unstructured":"Li, D. et al. Cancer survival in Cixian of China, 2003\u20132013: a population-based study. Cancer Med. 7 (4), 1537\u20131545 (2018).","journal-title":"Cancer Med."},{"issue":"10","key":"24969_CR5","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3748\/wjg.v29.i10.1569","volume":"29","author":"W Leowattana","year":"2023","unstructured":"Leowattana, W., Leowattana, P. & Leowattana, T. Systemic treatment for metastatic colorectal cancer. World J. Gastroenterol. 29 (10), 1569\u20131588 (2023).","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"24969_CR6","first-page":"S23","volume":"30","author":"T Bekaii-Saab","year":"2024","unstructured":"Bekaii-Saab, T. A decade of progress: advances in the third-line treatment of patients with metastatic colorectal cancer. Am. J. Manag Care. 30 (2), S23\u2013s30 (2024).","journal-title":"Am. J. Manag Care"},{"issue":"14","key":"24969_CR7","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.7150\/ijbs.64077","volume":"17","author":"A Fan","year":"2021","unstructured":"Fan, A. et al. Immunotherapy in colorectal cancer: current achievements and future perspective. Int. J. Biol. Sci. 17 (14), 3837\u20133849 (2021).","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"24969_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li, Q. et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal. Transduct. Target. Ther. 9 (1), 266 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"11","key":"24969_CR9","first-page":"1535","volume":"9","author":"SC Lin","year":"2020","unstructured":"Lin, S. C. et al. Alleviation of Collagen-Induced arthritis by Crotonoside through modulation of dendritic cell differentiation and activation. Plants (Basel). 9 (11), 1535 (2020).","journal-title":"Plants (Basel)"},{"issue":"18","key":"24969_CR10","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.3390\/molecules27185804","volume":"27","author":"C Ma","year":"2022","unstructured":"Ma, C. et al. The identification of APOBEC3G as a potential prognostic biomarker in acute myeloid leukemia and a possible drug target for Crotonoside. Molecules 27 (18), 5804 (2022).","journal-title":"Molecules"},{"issue":"61","key":"24969_CR11","doi-asserted-by":"publisher","first-page":"103087","DOI":"10.18632\/oncotarget.20710","volume":"8","author":"YZ Li","year":"2017","unstructured":"Li, Y. Z. et al. Crotonoside exhibits selective post-inhibition effect in AML cells via Inhibition of FLT3 and HDAC3\/6. Oncotarget 8 (61), 103087\u2013103099 (2017).","journal-title":"Oncotarget"},{"issue":"10","key":"24969_CR12","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1080\/09168451.2020.1789837","volume":"84","author":"Y Ma","year":"2020","unstructured":"Ma, Y. et al. Combination of diethyldithiocarbamate with 12-O-tetradecanoyl phorbol-13-acetate inhibits the growth of human myeloid leukemia HL-60 cells in vitro and in xenograft model. Biosci. Biotechnol. Biochem. 84 (10), 2069\u20132076 (2020).","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"1","key":"24969_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/00498254.2016.1276311","volume":"48","author":"P Yan","year":"2018","unstructured":"Yan, P., Zhang, L., Peng, C. & Zhang, R. Pharmacokinetics and tissue distribution of Crotonoside. Xenobiotica 48 (1), 28\u201336 (2018).","journal-title":"Xenobiotica"},{"issue":"1","key":"24969_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jep.2008.01.023","volume":"117","author":"X Wang","year":"2008","unstructured":"Wang, X. et al. Effects of essential oil from Croton tiglium L. on intestinal transit in mice. J. Ethnopharmacol. 117 (1), 102\u2013107 (2008).","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"24969_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4048\/jbc.2017.20.3.234","volume":"20","author":"HK Song","year":"2017","unstructured":"Song, H. K. et al. Crotonis fructus extract inhibits 12-O-Tetradecanoylphorbol-13-Acetate-Induced expression of matrix Metalloproteinase-9 via the activator Protein-1 pathway in MCF-7 cells. J. Breast Cancer. 20 (3), 234\u2013239 (2017).","journal-title":"J. Breast Cancer"},{"issue":"5","key":"24969_CR16","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.31557\/APJCP.2020.21.5.1369","volume":"21","author":"WM Aboulthana","year":"2020","unstructured":"Aboulthana, W. M. et al. Evaluation of the biological efficiency of silver nanoparticles biosynthesized using Croton tiglium L. Seeds extract against azoxymethane induced colon cancer in rats. Asian Pac. J. Cancer Prev. 21 (5), 1369\u20131389 (2020).","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"24969_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1200\/JCO.22.01690","volume":"41","author":"VK Morris","year":"2023","unstructured":"Morris, V. K. et al. Treatment of metastatic colorectal cancer: ASCO guideline. J. Clin. Oncol. 41 (3), 678\u2013700 (2023).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"24969_CR18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","volume":"43","author":"R Abedizadeh","year":"2024","unstructured":"Abedizadeh, R., Majidi, F., Khorasani, H. R., Abedi, H. & Sabour, D. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer Metastasis Rev. 43 (2), 729\u2013753 (2024).","journal-title":"Cancer Metastasis Rev."},{"issue":"2","key":"24969_CR19","doi-asserted-by":"publisher","first-page":"e13195","DOI":"10.1016\/j.heliyon.2023.e13195","volume":"9","author":"Z Jin","year":"2023","unstructured":"Jin, Z. et al. Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer. Heliyon 9 (2), e13195 (2023).","journal-title":"Heliyon"},{"issue":"2","key":"24969_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejcb.2018.12.002","volume":"98","author":"WD Wu","year":"2019","unstructured":"Wu, W. D., Yu, K. W., Zhong, N., Xiao, Y. & She, Z. Y. Roles and mechanisms of Kinesin-6 KIF20A in spindle organization during cell division. Eur. J. Cell. Biol. 98 (2), 74\u201380 (2019).","journal-title":"Eur. J. Cell. Biol."},{"issue":"21","key":"24969_CR21","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1093\/emboj\/19.21.5711","volume":"19","author":"E Hill","year":"2000","unstructured":"Hill, E., Clarke, M. & Barr, F. A. The Rab6-binding kinesin, Rab6-KIFL, is required for cytokinesis. Embo J. 19 (21), 5711\u20135719 (2000).","journal-title":"Embo J."},{"issue":"6","key":"24969_CR22","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1083\/jcb.201003095","volume":"191","author":"SH Lee","year":"2010","unstructured":"Lee, S. H., McCormick, F. & Saya, H. Mad2 inhibits the mitotic Kinesin MKlp2. J. Cell. Biol. 191 (6), 1069\u20131077 (2010).","journal-title":"J. Cell. Biol."},{"issue":"7","key":"24969_CR23","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1080\/01635581.2013.810290","volume":"65","author":"YL Liu","year":"2013","unstructured":"Liu, Y. L. et al. Genistein induces G2\/M arrest in gastric cancer cells by increasing the tumor suppressor PTEN expression. Nutr. Cancer. 65 (7), 1034\u20131041 (2013).","journal-title":"Nutr. Cancer"},{"issue":"10","key":"24969_CR24","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1016\/j.apsb.2022.05.021","volume":"12","author":"J Wei","year":"2022","unstructured":"Wei, J. et al. Cucurbitacin B-induced G2\/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78-FOXM1-KIF20A pathway. Acta Pharm. Sin B. 12 (10), 3861\u20133876 (2022).","journal-title":"Acta Pharm. Sin B"},{"issue":"12","key":"24969_CR25","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1158\/0008-5472.CAN-16-3566","volume":"77","author":"AL Gartel","year":"2017","unstructured":"Gartel, A. L. FOXM1 in cancer: interactions and vulnerabilities. Cancer Res. 77 (12), 3135\u20133139 (2017).","journal-title":"Cancer Res."},{"issue":"5","key":"24969_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/2159-8290.CD-17-0533","volume":"8","author":"J Port","year":"2018","unstructured":"Port, J. et al. Colorectal tumors require NUAK1 for protection from oxidative stress. Cancer Discov. 8 (5), 632\u2013647 (2018).","journal-title":"Cancer Discov"},{"issue":"10","key":"24969_CR27","doi-asserted-by":"publisher","first-page":"13515","DOI":"10.18632\/aging.202774","volume":"13","author":"C Yang","year":"2021","unstructured":"Yang, C., Zhang, Y., Lin, S., Liu, Y. & Li, W. Suppressing the KIF20A\/NUAK1\/Nrf2\/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin. Aging (Albany NY). 13 (10), 13515\u201313534 (2021).","journal-title":"Aging (Albany NY)"},{"issue":"24","key":"24969_CR28","doi-asserted-by":"publisher","first-page":"11905","DOI":"10.18632\/aging.102505","volume":"11","author":"M Xiong","year":"2019","unstructured":"Xiong, M. et al. KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK\/STAT3 signaling pathway. Aging (Albany NY). 11 (24), 11905\u201311921 (2019).","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"24969_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12935-020-01631-y","volume":"20","author":"H Yu","year":"2020","unstructured":"Yu, H. et al. FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A. Cancer Cell. Int. 20 (1), 545 (2020).","journal-title":"Cancer Cell. Int."},{"issue":"6","key":"24969_CR30","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3390\/cancers15061724","volume":"15","author":"KU Rahman","year":"2023","unstructured":"Rahman, K. U. et al. Mir-153-3p modulates the breast cancer cells\u2019 chemosensitivity to doxorubicin by targeting KIF20A. Cancers (Basel). 15 (6), 1724 (2023).","journal-title":"Cancers (Basel)"},{"key":"24969_CR31","doi-asserted-by":"publisher","first-page":"1517708","DOI":"10.3389\/fphar.2024.1517708","volume":"15","author":"X Cheng","year":"2024","unstructured":"Cheng, X. et al. Parishin B blocking TRIB3-AKT1 interaction inhibits breast cancer lung metastasis. Front. Pharmacol. 15, 1517708 (2024).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"24969_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12935-025-03727-9","volume":"25","author":"J Sun","year":"2025","unstructured":"Sun, J. et al. Schisandrin B exerts anti-colorectal cancer effect through CXCL2\/ERK\/DUSP11 signaling pathway. Cancer Cell. Int. 25 (1), 97 (2025).","journal-title":"Cancer Cell. Int."},{"key":"24969_CR33","doi-asserted-by":"publisher","first-page":"1506499","DOI":"10.3389\/fphar.2025.1506499","volume":"16","author":"X Wang","year":"2025","unstructured":"Wang, X. et al. Gentiopicroside targeting AKT1 activates HIF-1\u03b1\/VEGF axis promoting diabetic ulcer wound healing. Front. Pharmacol. 16, 1506499 (2025).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24969-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24969-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24969-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:51:25Z","timestamp":1763635885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24969-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24969"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24969-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41022"}}